IP Library Granted Patent US 12,708,399
Granted Patent B2
US 12,708,399 · App. 17/857,326 · Granted Aug 18, 2026

Transcatheter valve laceration device and method

Inventors: Erez Golan (Rehovot, IL); Benzion Spector (Tel Mond, IL)
Assignee: PI-CARDIA LTD.
A61B17/320725A61F2/2427A61B2017/00783
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,708,399
App. No.
17/857,326
Filed
Jul 5, 2022
Granted
Aug 18, 2026
Kind
B2
Art Unit
3774
USPC
623/2.11
Abstract

A transcatheter valve laceration device includes a leaflet support frame and a leaflet cutting assembly, both of which are movably mounted on a guiding structure and movable between contracted and expanded orientations. In the expanded orientation, a blade protector of the leaflet support frame is positioned over a cutting element of the leaflet cutting assembly.

Claims (10)

1 . A method for lacerating heart tissue comprising:

using a device that comprises a leaflet support frame and a leaflet cutting assembly, both of which are movably mounted on a guiding structure and movable between contracted and expanded orientations, wherein said leaflet cutting assembly comprises a cutting element that comprises a sharp blade arm that has a pointed sharp tip at a distal end of said sharp blade arm, and a blade actuator arm pivotally coupled to said sharp blade arm, wherein in the expanded orientation, a blade protector of said leaflet support frame is positioned over said pointed sharp tip of said cutting element of said leaflet cutting assembly,

introducing said device with said leaflet support frame and said leaflet cutting assembly in contracted orientations to a heart;

expanding said leaflet support frame;

expanding said leaflet cutting assembly; and

moving said leaflet cutting assembly to lacerate heart tissue located between said cutting element and said blade protector.

2 . The method according to claim 1 , comprising first piercing said heart tissue with said pointed sharp tip of said cutting element of said leaflet cutting assembly prior to moving said leaflet cutting assembly to lacerate the heart tissue.

3 . The method according to claim 1 , comprising lacerating the heart tissue in a mitral anterior leaflet laceration procedure as part of a transcatheter mitral valve replacement (TMVR) procedure to prevent LVOT (left ventricle outflow tunnel) obstruction when an implant valve is positioned within a native valve of a patient.

4 . The method according to claim 1 , wherein said heart tissue comprises tissue of a mitral valve.

5 . The method according to claim 1 , wherein expanding said leaflet cutting assembly comprises one end of said blade actuator arm pivoting with respect to said guiding structure and an opposite end of said blade actuator arm pivoting with respect to said sharp blade arm proximal to said pointed sharp tip.

Assignments (4)
SECURITY INTEREST Recorded Feb 23, 2026
From: PI-CARDIA LTD.
To: KREOS CAPITAL VI (EXPERT FUND) LP
Reel/Frame 074485/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2025
From: GOLAN, EREZ; SPECTOR, BENZION
To: PI-CARDIA LTD.
Reel/Frame 072808/0373 →
SECURITY INTEREST Recorded Jun 3, 2025
From: PI-CARDIA LTD.
To: KREOS CAPITAL VI (EXPERT FUND) LP
Reel/Frame 071463/0524 →
SECURITY INTEREST Recorded Jan 8, 2024
From: PI-CARDIA LTD
To: KREOS CAPITAL VI (EXPERT FUND) L.P.
Reel/Frame 066208/0842 →
Continuity (2)
Provisional Application 63220588 · Jul 12, 2021
Related Publication 20230010485A1 · Jan 12, 2023
References Cited (30)
US 5047041A · Samuels · 1991 [cited by applicant]
US 5613937A · Garrison et al. · 1997 [cited by applicant]
US 6830584B1 · Seguin · 2004 [cited by applicant]
US 9364255B2 · Weber · 2016 [cited by examiner]
US 20040034380A1 · Woolfson et al. · 2004 [cited by applicant]
US 20050131438A1 · Cohn · 2005 [cited by applicant]
US 20050203549A1 · Realyvasquez · 2005 [cited by applicant]
US 20070185513A1 · Woolfson et al. · 2007 [cited by applicant]
US 20100076476A1 · To et al. · 2010 [cited by applicant]
US 20100286719A1 · Paul et al. · 2010 [cited by applicant]
US 20130066346A1 · Pigott · 2013 [cited by applicant]
US 20130116715A1 · Weber · 2013 [cited by applicant]
US 20150359556A1 · Vardi · 2015 [cited by applicant]
US 20160100855A1 · Lemaitre et al. · 2016 [cited by applicant]
US 20160166243A1 · Wilson et al. · 2016 [cited by applicant]
US 20170209160A1 · Pigott · 2017 [cited by applicant]
US 20180000509A1 · Wilson et al. · 2018 [cited by applicant]
US 20180064460A1 · Vardi et al. · 2018 [cited by applicant]
US 20180092661A1 · Prabhu · 2018 [cited by applicant]
US 20190029790A1 · Bak-Boychuk et al. · 2019 [cited by applicant]
US 20190069920A1 · Astarci · 2019 [cited by examiner]
US 20190209315A1 · Zhang et al. · 2019 [cited by applicant]
US 20190298517A1 · Sanchez et al. · 2019 [cited by applicant]
US 20200289102A1 · Wilson · 2020 [cited by examiner]
US 20210085456A1 · Skarsgard · 2021 [cited by examiner]
AU 2006211174 · 2006 [cited by applicant]
CN 1418074 · 2003 [cited by applicant]
CN 102985018 · 2013 [cited by applicant]
CN 104812318 · 2015 [cited by applicant]
CN 109561891 · 2019 [cited by applicant]